LIDOCAINE HYDROCHLORIDE solution

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

LIDOCAINE HYDROCHLORIDE ANHYDROUS (UNII: EC2CNF7XFP) (LIDOCAINE - UNII:98PI200987)

Pieejams no:

A-S Medication Solutions

SNN (starptautisko nepatentēto nosaukumu):

LIDOCAINE HYDROCHLORIDE ANHYDROUS

Kompozīcija:

LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg in 1 mL

Ievadīšanas:

ORAL

Receptes veids:

PRESCRIPTION DRUG

Ārstēšanas norādes:

Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2% is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. It is also useful for reducing gagging during the taking of X-ray pictures and dental impressions. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type, or to other components of the solution.

Produktu pārskats:

Product: 50090-0255 NDC: 50090-0255-0 100 mL in a BOTTLE, PLASTIC

Autorizācija statuss:

Abbreviated New Drug Application

Produkta apraksts

LIDOCAINE HYDROCHLORIDE- LIDOCAINE HYDROCHLORIDE SOLUTION
A-S MEDICATION SOLUTIONS
----------
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
RX ONLY
A Topical Anesthetic for the Mucous Membranes of the Mouth and
Pharynx.
FOR ORAL USE ONLY
WARNING: LIFE-THREATENING AND FATAL EVENTS IN INFANTS AND YOUNG
CHILDREN
Postmarketing cases of seizures, cardiopulmonary arrest, and death in
patients
under the age of 3 years have been reported with use of Lidocaine
Hydrochloride
Oral Topical Solution, USP (Viscous) 2% when it was not administered
in strict
adherence to the dosing and administration recommendations. In the
setting of
teething pain, Lidocaine Hydrochloride Oral Topical Solution, USP
(Viscous) 2%
should generally not be used. For other conditions, the use of the
product in
patients less than 3 years of age should be limited to those
situations where safer
alternatives are not available or have been tried but failed.
To decrease the risk of serious adverse events with use of Lidocaine
Hydrochloride
Oral Topical Solution, USP (Viscous) 2%, instruct caregivers to
strictly adhere to the
prescribed dose and frequency of administration and store the
prescription bottle
safely out of reach of children.
DESCRIPTION
Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%
contains a local
anesthetic agent and is administered topically. Lidocaine
Hydrochloride Oral Topical
Solution, USP (Viscous) 2% contains lidocaine hydrochloride, which is
chemically
designated as acetamide, 2-(diethylamino)-N- (2,6 dimethylphenyl)-,
monohydrochloride
and has the following structural formula:
The molecular formula of lidocaine is C
H
N O. The molecular weight is 234.34.
COMPOSITION OF SOLUTION
Each mL contains 20 mg of lidocaine HCl. In addition each mL contains
the following
inactive ingredients: carboxymethylcellulose sodium USP, methylparaben
NF, natural
orange flavor, propylparaben NF, purified water USP, and saccharin
sodium USP. The pH
is adjusted to 5.0 to 7.0 by means of hydrochloric acid and/or sodium
hy